Clinical trial
A Randomized Controlled Trial of Acceptance and Commitment Therapy (ACT) in Inflammatory Bowel Disease
NCT02350920 is registered in ClinicalTrials.gov with University College Dublin as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Controlled Trial of Acceptance and Commitment Therapy (ACT) in Inflammatory Bowel Disease
- Lead sponsor
- University College Dublin
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 30, 2015
- Completion date
- March 31, 2017
- Enrollment
- 95 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
inflammatory bowel disease